Back

Ticagrelor-based dual antithrombotic therapy in anticoagulated patients undergoing PCI: a pooled analysis of two multicenter registries

30 August 2026 (17:15 - 18:00)
Organised by: Logo
Congress Presentation Part of: Updates on dual antiplatelet therapy Antiplatelet Drugs ESC Professional Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Miss Qiu Ying Fu Van De Pol

St Antonius Hospital, Nieuwegein (Netherlands (The))

3 More presentations in this session

Presentation thumbnail
Efficacy and safety of short (≤6 months) versus prolonged (>6 months) dual antiplatelet therapy following percutaneous coronary intervention: a systematic review and meta-analysis
Mr A. Gasca (Cali, CO)
Abstract Slides Video
Presentation thumbnail
PRECISE-DAPT Score fails to predict clinically relevant bleeding in elderly patients with ACS
Doctor M. Santos Silva (Aveiro, PT)
Abstract Slides Video
Presentation thumbnail
Efficacy and safety of prasugrel monotherapy compared with clopidogrel in Japanese patients with acute coronary syndrome after percutaneous coronary intervention
Doctor E. Nawata (Suita, JP)
Abstract Slides Video

Access the full session

Session thumbnail
Updates on dual antiplatelet therapy

The Event

Event poster

ESC Congress 2026

30 August 2026 17:15 CET
You may be interested in
thumbnail
Congress Presentation
Ticagrelor monotherapy or DAPT after drug-eluting coronary stenting in patients with or without acute coronary syndrome: a patient-level meta-analysis of randomized controlled trials
31 August 2024
thumbnail
Congress Presentation
Effect of combined antiplatelet and anticoagulant therapy in comparison to anticoagulants in monotherapy on CABG outcomes in patients requiring anticoagulants. Analysis of real-world data.
30 August 2026
thumbnail
Congress Presentation
Ticagrelor versus clopidogrel in patients with acute coronary syndrome undergoing percutaneous coronary intervention and using direct oral anticoagulants
29 August 2025
thumbnail
Congress Presentation
Efficacy and safety of antithrombotic strategies for atrial fibrillation in patients with chronic coronary syndrome according to coronary treatment strategy: a meta-analysis of randomized trials
28 August 2026

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources